XML 24 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Note 8 - Stockholders' Equity
9 Months Ended
Oct. 31, 2020
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

8. Stockholders’ Equity

 

The following table sets forth the changes in stockholders’ equity (in thousands) for the thirteen weeks ended  October 31, 2020 and November 2, 2019 (in thousands):

 

  

For the thirteen weeks ended October 31, 2020

  

For the thirteen weeks ended November 2, 2019

 
                                         
  

Common

          

Retained

      

Common

          

Retained

     
  

stock

  

APIC (1)

  

AOCI (2)

  

earnings/(deficit)

  

Total

  

stock

  

APIC (1)

  

AOCI (2)

  

earnings/(deficit)

  

Total

 

Balance, beginning

 $156  $71,906  $(12,303) $(5,188) $54,571  $152  $70,295  $(11,579) $29,637  $88,505 
Issuance of restricted/performance stock $4  $(4)          -     $(1)          (1)
Stock-based compensation      441           441       (340)          (340)
Shares withheld in lieu of tax withholdings                  -                   - 
Other      1           1       1   1   (1)  1.00 
Other comprehensive income (loss)          26       26           (349)      (349)
Net income (loss)              1,660   1,660               (5,873)  (5,873)

Balance, ending

 $160  $72,344  $(12,277) $(3,528) $56,699  $152  $69,955  $(11,927) $23,763  $81,943 

 

(1) - Additional paid-in capital (“APIC”)

(2) - Accumulated other comprehensive income (loss) (“AOCI”)

 

The following table sets forth the changes in stockholders’ equity (in thousands) for the thirty-nine weeks ended October 31, 2020 and November 2, 2019 (in thousands):

 

  

For the thirty-nine weeks ended October 31, 2020

  

For the thirty-nine weeks ended November 2, 2019

 
                                         
  

Common

          

Retained

      

Common

          

Retained

     
  

stock

  

APIC (1)

  

AOCI (2)

  

earnings/(deficit)

  

Total

  

stock

  

APIC (1)

  

AOCI (2)

  

earnings/(deficit)

  

Total

 

Balance, beginning

 $152  $70,633  $(12,079) $29,925  $88,631  $150  $69,088  $(12,018) $37,094  $94,314 

Adoption of new accounting standard

  -   -   -   -   -   -   -   -   (7,430)  (7,430)

Subtotal

 $152  $70,633  $(12,079) $29,925  $88,631  $150  $69,088  $(12,018) $29,664  $86,884 

Issuance of restricted/performance stock

  8   491           499   2   (248)          (246)

Stock-based compensation

      1,334           1,334       1,114           1,114 

Shares withheld in lieu of tax withholdings

  (1)  (114)          (115)                  - 

Other

  1              1       1   (1)      0 
Other comprehensive income (loss)          (198)      (198)          92       92 

Net loss

              (33,453)  (33,453)              (5,901)  (5,901)

Balance, ending

 $160  $72,344  $(12,277) $(3,528) $56,699  $152  $69,955  $(11,927) $23,763  $81,943 

 

(1) - Additional paid-in capital (“APIC”)

(2) - Accumulated other comprehensive income (loss) (“AOCI”)

 

In August 2017, the Company’s Board of Directors authorized a share repurchase program of up to $20.0 million. From the date of such authorization through the program expiration on September 30, 2020, the Company had repurchased approximately 1.3 million shares at an average price of $8.75 per share for an aggregate amount of approximately $11.2 million. The Company does not plan to utilize cash to resume share repurchases in fiscal 2020. In addition, the Company's ability to repurchase shares is limited by conditions set forth by its lender in its credit agreement, as described below.